Department of Biostatistics and Translational Medicine Medical University of Lodz Lodz Poland

Department of Hematology Frederic Chopin Provincial Specialist Hospital Rzeszow Poland

Department of Microbiology and Clinical Immunology Children's Memorial Health Institute Warsaw Poland

Department of Oncology The Children's Memorial Health Institute Warsaw Poland

Department of Pathology Chair of Oncology Medical University of Lodz Lodz Poland

Department of Pathology The Children's Memorial Health Institute Warsaw Poland

Department of Pediatric Hematology Oncology and Transplantology Medical University of Wroclaw Wroclaw Poland

Department of Pediatric Oncology University Hospital and Faculty of Medicine Masaryk University Brno Czech Republic; Department of Pediatric Oncology University Hospital Brno and Faculty of Medicine Masaryk University Brno Czech Republic

Department of Pediatrics Oncology and Hematology Medical University of Lodz Lodz Poland

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands; Department of Genetics Utrecht University Medical Center Utrecht University Utrecht The Netherlands

Zobrazit více v PubMed

Szmyd B, Mlynarski W, Pastorczak A. Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants. Mutat Res Rev Mutat Res. 2021;788:108386. PubMed

Pastorczak A, Attarbaschi A, Bomken S, et al. Consensus recommendations for the clinical management of hematological malignancies in patients with DNA double stranded break disorders. Cancers. 2022;14(8):2000. PubMed PMC

Wolska-Kusnierz B, Pastorczak A, Fendler W, et al. Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome. Clin Cancer Res. 2021;27(2):575-584. PubMed

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390. PubMed PMC

Gutiérrez-García G, Cardesa-Salzmann T, Climent F, et al. Geneexpression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood. 2011;117(18):4836-4843. PubMed

Ye X, Ren W, Liu D, et al. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas. J Exp Med. 2021;218(2):e20200573. PubMed PMC

Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415-421. PubMed PMC

Lopez-Santillan M, Lopez-Lopez E, Alvarez-Gonzalez P, et al. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: a systematic review. Crit Rev Oncol Hematol. 2021;165:103430. PubMed

Huang S, Nong L, Liang L, et al. Comparison of PD-L1 detection assays and corresponding significance in evaluation of diffuse large B-cell lymphoma. Cancer Med. 2019;8(8):3831-3845. PubMed PMC

Kwon HJ, Yang JM, Lee J-O, Lee JS, Paik JH. Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma. J Transl Med. 2018;16(1):320. PubMed PMC

Wang Y, Wenzl K, Manske MK, et al. Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma. Blood Cancer J. 2019;9(9):73. PubMed PMC

Jain MD, Ziccheddu B, Coughlin CA, et al. Genomic drivers of large B-cell lymphoma resistance to CD19 CAR-T therapy. Blood. 2021;138(Suppl 1):S42.

Sapio L, Di Maiolo F, Illiano M, et al. Targeting protein kinase a in cancer therapy: an update. EXCLI J. 2014;13:843-855. PubMed PMC

Ahmed MB, Alghamdi AAA, Islam SU, Lee J-S, Lee Y-S. cAMP Signaling in cancer: a PKA-CREB and EPAC-centric approach. Cells. 2022;11(13):2020. PubMed PMC

Georgiou K, Chen L, Berglund M, et al. Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. Blood. 2016;127(24):3026-3034. PubMed

Zapatka M, Borozan I, Brewer DS, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320-330. PubMed PMC

Li M, Du M, Cong H, et al. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatol Res. 2021;51(1):102-115. PubMed